| 摘要 |
The present invention refers to clathrates of dehydroepiandrosterone, possibly in the form of sulphate, in a matrix consisting of a cyclodextrin and optionally comprising a co-solubilization agent, and to the corresponding pharmaceutical compositions suitable for replacement therapy for the treatment of adrenocortical insufficiency. |
